Publication | Open Access

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

Tumor ImmunologyCancer ImmunosurveillanceImmunologyTherapeutic VaccineComplement RegulatorsImmune Checkpoint InhibitorAutoimmunityAntibody EngineeringImmunotherapyMedicineRadiation OncologyTumor MicroenvironmentTumor BiologyAntibody-based ImmunotherapyBispecific Antibodies